Cargando…
Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
PURPOSE: The glycolytic enzyme fructose 1,6-bisphosphate aldolase B (ALDOB) is aberrantly expressed and impacts the prognosis in hepatocellular carcinoma (HCC). Hepatic ALDOB loss leads to paradoxical upregulation of glucose metabolism, favoring hepatocellular carcinogenesis. Nevertheless, the relat...
Autores principales: | Jia, Wenzhi, Wu, Qianyun, Yu, Xiaofeng, Shen, Mengqin, Zhang, Ruixue, Li, Jiajin, Zhao, Li, Huang, Gang, Liu, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834807/ https://www.ncbi.nlm.nih.gov/pubmed/36644641 http://dx.doi.org/10.3389/fonc.2022.1044902 |
Ejemplares similares
-
Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to (18)F-FDG PET/CT
por: Zheng, Dong, et al.
Publicado: (2020) -
Prognostic Values of TIGAR Expression and (18)F-FDG PET/CT in Clear Cell Renal Cell Carcinoma
por: Wang, Xiaoyan, et al.
Publicado: (2020) -
Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015) -
Diagnostic Value of (18)F-FDG-PET/CT in Patients with FUO
por: Georga, Stamata, et al.
Publicado: (2020) -
Differential diagnostic value of (18)F-FDG PET/CT in osteolytic lesions
por: Li, Xiaomeng, et al.
Publicado: (2020)